Keyphrases
Benefit-risk Assessment
100%
Cataract
25%
Clinical Outcomes
25%
Comparative Effectiveness Trial
25%
Confidence Interval
25%
Corticosteroid Implant
25%
Eye Surgery
25%
Glaucoma
25%
Hypertension
25%
Implant Therapy
50%
Life Data
25%
Multiple Outcomes
25%
Non-infectious
25%
Panuveitis
25%
Patient Benefit
25%
Patient Preference
50%
Patient-centered Approach
100%
Quality Measures
25%
Quality of Life
50%
Risk-benefit Ratio
50%
Steroid Treatment
25%
Systemic Corticosteroids
25%
Systemic Immunosuppression
25%
Systemic Therapy
75%
Treatment Decisions
100%
Treatment Trials
25%
Uveitis
100%
Visual Acuity
25%
Medicine and Dentistry
Cataract
33%
Corticosteroid
33%
Decision Making
100%
Eye Surgery
33%
Glaucoma
33%
Hyperlipidemia
33%
Immunosuppressive Treatment
33%
Implant
33%
Infection
33%
Patient Preference
66%
Quality of Life
66%
Steroid Treatment
33%
Systemic Therapy
100%
Uveitis
100%
Visual Acuity
33%
Weakness
33%
Nursing and Health Professions
Cataract
33%
Clinical Outcome
33%
Confidence Interval
33%
Corticosteroid
33%
Eye Surgery
33%
Glaucoma
33%
Hyperlipidemia
33%
Immunosuppressive Treatment
33%
Implant
33%
Infection
33%
Patient Preference
66%
Quality of Life
66%
Systemic Therapy
100%
Uveitis
100%
Visual Acuity
33%
Weakness
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cataract
33%
Corticosteroid
33%
Glaucoma
33%
Hyperlipidemia
33%
Implant
33%
Infection
33%
Steroid Treatment
33%
Uveitis
100%
Weakness
33%
Immunology and Microbiology
Decision Making
100%
Immunosuppression
33%
Uveitis
100%
Visual Acuity
33%